Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07231627 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Jun 2026 to Jun 19, 2026v8
  2. Recruitment opened
    • Site details revised
    v7
  3. Start date: May 2026 to Jun 2026v6
  4. Re-verified, no change to tracked fieldsv5
  5. Study sites: 0 to 1v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Mar 2026 to May 2026v3
  2. Start date: Jan 2026 to Mar 2026v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Use of AI algorithm for PCa detection is feasible, and AI-informed biopsies (AI-targeted and perilesional biopsy) improves csPCa detection in patients with indeterminate MRI lesions and in patients with low-risk MRI lesions and high-risk clinical features.
Trial Details
NCT Number NCT07231627
Lead Sponsor University of Arkansas
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov